Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Market Cap	10.64B
Revenue (ttm)	9.28B
Net Income (ttm)	417.67M
Shares Out	696.68M
EPS (ttm)	0.60
PE Ratio	11.48
Forward PE	16.15
Dividend	0.30 (4.35%)
Ex-Dividend Date	n/a

Volume	1,022,000
Average Volume	929,348
Open	6.87
Previous Close	6.90
Day's Range	6.85 - 6.90
52-Week Range	5.11 - 9.46
Beta	-0.11
RSI	48.01
Earnings Date	Mar 30, 2026

About HKG:0719

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 7,296
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0719

Financial Performance

In 2024, HKG:0719's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY